Beta Bionics (BBNX) Total Liabilities (2023 - 2026)

Beta Bionics' Total Liabilities history runs 4 years deep, the most recent figure standing at $33.2 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 36.67% year-over-year to $33.2 million; the TTM figure through Mar 2026 stood at $33.2 million (up 36.67% YoY), while the FY2025 annual figure was $41.1 million, down 44.14% from the prior year.
• Total Liabilities came in at $33.2 million for Q1 2026 at Beta Bionics, down from $41.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $228.8 million in Q3 2024 to a low of $24.3 million in Q1 2025.
• A 4-year average of $95.2 million and a median of $46.3 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities soared 43.16% in 2024 and plunged 88.68% in 2025, its largest moves.
• Beta Bionics' Total Liabilities stood at $51.4 million in 2023, then jumped by 43.16% to $73.6 million in 2024, then slumped by 44.14% to $41.1 million in 2025, then declined by 19.35% to $33.2 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $33.2 million, $41.1 million, and $35.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison